2015
DOI: 10.1021/jo502330w
|View full text |Cite
|
Sign up to set email alerts
|

“Catch-and-Release” of HNO with Pyrazolones

Abstract: A new and versatile class of HNO donors, the (hydroxylamino)pyrazolone (HAPY) series of HNO donors utilizing pyrazolone (PY) leaving groups, is described. HNO, the smallest N-based aldehyde equivalent, is used as a reagent along with a variety of PY compounds to synthesize the desired HAPY donors in what can be considered an N-selective HNO-aldol reaction in up to quantitative yields. The bimolecular rate constant of HNO with PY in pH 7.4 phosphate buffer at 37 °C can reach 8 × 10(5) M(-1) s(-1). In (1)H NMR e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
35
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 34 publications
(37 citation statements)
references
References 51 publications
2
35
0
Order By: Relevance
“…86 In addition, this work shows the pyrazolone by-product reacts reversibly with HNO via an HNO-aldol reaction. 85 These new structurally diverse HNO donors with extended half-lives hold promise as pharmacological tools and therapeutics.…”
Section: Advances In Hno Sourcesmentioning
confidence: 99%
“…86 In addition, this work shows the pyrazolone by-product reacts reversibly with HNO via an HNO-aldol reaction. 85 These new structurally diverse HNO donors with extended half-lives hold promise as pharmacological tools and therapeutics.…”
Section: Advances In Hno Sourcesmentioning
confidence: 99%
“…6,7 Piloty's acid (PA) and its derivatives, with sulfinate leaving groups, are classic examples of this strategy. 8−12 Piloty's acid itself is quite stable at pH 7.4 (t 1/2 > 1 h) but under physiological conditions can be oxidized, presumably to the corresponding nitroxide, and become an NO donor.…”
Section: ■ Introductionmentioning
confidence: 99%
“…6 However, the HAPY class is resistant to alternative non-HNO producing mechanisms, and the first series extension of this class is the subject of a companion paper. 7 Accessing longer lived HNO donors with half-lives on the order of minutes to hours, particularly within the same donor class, is expected to have a broad impact on optimizing HNO release rate for the treatment of any number of potential diseases, including congestive heart failure, alcoholism, vascular dysfunction, and cancer. Furthermore, sustained release of low concentrations of HNO might be an important step to mimic hypothesized endogenous HNO generation.…”
Section: ■ Introductionmentioning
confidence: 99%
See 2 more Smart Citations